Jorgensen Biotech Consulting ApS: Financial statements 2026
CVR: 42981761
Source: annual report 2026, Danish Business Authority
01/07/2025 – 30/06/2026
Jorgensen Biotech Consulting ApS (CVR 42981761) has filed annual accounts for 2026. In 2026, the company reported a gross profit of DKK 3,669,337 and a net result of DKK 462,628 compared with DKK -373,758 the year before. That is an increase of 36.7% compared with the year before. Equity in the 2026 report amounted to DKK 328,288. The solvency ratio was 30.7%. The company had 1 employee in the financial year.
- Gross Profit
- DKK 3,669,337
- Profit/Loss
- DKK 462,628
- Equity
- DKK 328,288
- Total Assets
- DKK 1,069,625
- Employees
- 1
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2026 | - | 3.7M | 463K | 328K | 1 |
| 2025 | - | 2.7M | -374K | -134K | 1 |
| 2024 | - | 2.4M | 247K | 361K | 1 |
Official annual report
Find more companies like Jorgensen Biotech Consulting ApS
Build lead lists with filters on industry, geography, size and financials, and export straight to Excel.
Try the lead list generatorEvents in 2026
Address changed to Dronningens Vænge 11 st. tv, 2800 Kongens Lyngby (April 1, 2026).
About Jorgensen Biotech Consulting ApS
Jorgensen Biotech Consulting ApS is a Danish company of the type Anpartsselskab based in Kongens Lyngby, founded in 2022. The company is registered under the industry Virksomhedsrådgivning og anden ledelsesrådgivning. The management consists of Thomas Kjærsgaard Jørgensen. The company is owned by JoBiCo Holding ApS. The company has 2 employees (2026). In 2026, the company reported a gross profit of DKK 3,669,337 and a net result of DKK 462,628 compared with DKK -373,758 the year before. Equity in the 2026 report amounted to DKK 328,288.
